First Cited
Last Cited

Articles citing This Document (Page 1 of 1)

Type 2 Cardiorenal Syndrome2021
Range of adiposity and cardiorenal syndromeWorld Journal of Diabetes2020
Consensus document: management of heart failure in type 2 diabetes mellitusHeart Failure Reviews2021
Heart failure with mid-range or mildly reduced ejection fractionNature Reviews Cardiology2021
Unveiling the role of exercise training in targeting the inflammatory paradigm of heart failure with preserved ejection fraction: a narrative reviewHeart Failure Reviews2021
Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fractionPharmacotherapy2021
Optimizing Management of Type 2 Diabetes and Its Complications in Patients With Heart FailureClinical Diabetes2021
SGLT2-inhibitors; more than just glycosuria and diuresisHeart Failure Reviews2021
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysisJAMA Cardiology2021
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease PreventionAmerican Journal of Cardiovascular Drugs2020
Congestion in heart failure: a contemporary look at physiology, diagnosis and treatmentNature Reviews Cardiology2020
Advances in Clinical Cardiology 2019: A Summary of Key Clinical TrialsAdvances in Therapy2020
Are SGLT-2 Inhibitors the Future of Heart Failure Treatment? The EMPEROR-Preserved and EMPEROR-Reduced TrialsDiabetes Therapy2020
Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the BadCurrent Diabetes Reports2020
Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome TrialsDiabetes Therapy2020
Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart FailureEuropean Journal of Internal Medicine2020
Resistance to Diuretics in Heart Failure: Any Role for Empagliflozin?Current Vascular Pharmacology2019
Advances in the clinical management of type 2 diabetes: a brief history of the past 15 years and challenges for the futureBMC Medicine2019
Cardiologists' approach to managing cardiovascular risk in patients with type 2 diabetesJournal of Diabetes2019
Beyond type 2 diabetes: sodium glucose co-transporter-inhibition in type 1 diabetesDiabetes, Obesity and Metabolism2019
Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysisCardiovascular Diabetology2019
SGLT-2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic ProspectsJournal of the American Heart Association2019
Empagliflozin and Protecting Microvascular Support of Heart Mechanics: SGLT2 Inhibition or More?JACC Basic To Translational Science2019
Are Sodium-Glucose Cotransporter 2 Inhibitors Really Useful and Safe for Advanced Heart Failure?Circulation Journal2018
The treatment of type 2 diabetes in heart failurePractical Diabetes2018
Effect of glucose-lowering therapies on heart failureNature Reviews Cardiology2018
Novel Diabetes Drugs and the Cardiovascular SpecialistJournal of the American College of Cardiology2017